Combining genetics with real-world patient data enables ancestry-specific target identification and drug discovery in Alzheimer’s disease
Feixiong Cheng(Cleveland Clinic), Jeffrey L. Cummings(University of Nevada, Las Vegas)
Cited by 2
Related Papers
Alzheimer's disease drug development pipeline: 2023
|Alzheimer s & Dementia Translational Research & Clinical Interventions|2023|457
Designing the next-generation clinical care pathway for Alzheimer’s disease
|Nature Aging|2022|193
Burden of Illness in People with Alzheimer's Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality
|The Journal of Prevention of Alzheimer s Disease|2023|139